Rodrigo Ruiz Soto is Vice President of Clinical Development and Translational Medicine at Deciphera Pharmaceuticals. Dr. Ruiz Soto joined Deciphera in 2017 and is an experienced Clinical Development Hematologist-Oncologist with more than 15 years of experience in clinical research. Prior to joining Deciphera, he was Senior Medical Director at ImmunoGen where he played a key role in advancing antibody-drug conjugates from early to late-stage development. Prior to ImmunoGen, Dr. Soto served as Medical Director at Sanofi and before that at GSK working in various oncology indications from Phase 1 to Phase 3, including small molecules and biologics. Dr. Soto received an M.D. from the Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency and fellowship in hematology at the National Institute of Medical Sciences and Nutrition Salvador Zubiran in Mexico. Dr. Soto trained in medical oncology at the Institut de Cancerologie Gustave Roussy in France and received a Master of Science in Oncology from the Paris XI University-Institut Gustave Roussy.